Sample Genomind® Professional PGx ExpressTM Results Report

The Genomind Professional PGx Express report is intended to aid clinicians in making personalized treatment decisions tailored to a patient’s genetic background and can help to inform psychiatric treatments.

Review a sample results report below, including the genetic results summary and the drug interaction summary. These reports are only available to the clinician.

Genomind Professional PGx Express now includes two report options:

CORE Anxiety & Depression Report includes 15 key genes used to inform treatment decisions for anxiety and depression. (Now covered by United Healthcare)

FULL Mental Health Report includes 24 key genes used to inform treatment for a range of psychiatric conditions such as depression, anxiety, attention deficit hyperactivity disorder (ADHD), bipolar, substance abuse and more.

United Healthcare now has a coverage policy for Genomind Professional PGx Express CORE Anxiety & Depression Report (15 genes).  The report includes 15 key genes used to inform treatment decisions for Anxiety and Depression. Coverage is for patients that have a diagnosis of major depressive disorder or anxiety and have failed at least one prior medication to treat their condition.

Gene Variations

The Genomind Professional PGx Express report provides clinicians with the patient’s genetic results for genes that are known to impact mental health treatment. The gene results provide the patient genotype for each of the gene variants on our panel. The color coded genotype reflects the patients inherited alleles, or variants, at a particular location within the tested gene. The report also provides therapeutic implication information regarding the function of the tested gene.

Gene Drug Interaction Summary

Each patient report includes a gene-drug interaction summary. Genomind Professional PGx Express is a guide for clinicians in the selection of safe and appropriate medications based on the results of the report. The gene-drug interaction summary provides information about how the patient’s genetic profile interacts with medications commonly used in psychiatry. This summary table lists medications in alphabetical order by generic name and drug class.

Medication Interaction falls into two categories:

Summary Pages:

Diagnosis-specific Summary Pages will provide a visual plot of drugs and augmentation strategies for a particular condition. The visual plot will shift left or right based on known gene-drug interactions.

  • Alert/Caution: Drugs will shift to the left if a patient has genetic variations which may reduce efficacy, Increase likelihood of side effects, or alter drug metabolism absorption.

  • Standard Options: Drugs that are not shifted indicate that there are no gene-drug interactions for the patient.

  • PGx Express Guided Options: Drugs will be shifted to the right if the patient has genetic variations which may increase likelihood of efficacy.

Patient’s Genomind RX MetatypeTM Card

 

I’ve been using the Genecept Assay® for over three years and found that it helps me select the right medications for patients so that they can start feeling better more quickly.

Suzanne H. Grantham, PMHNPPsychiatric Mental Health Nurse Practitioner

} ); } ( jQuery ) );